BioProcess Insider Interview: Emmanuel Ligner, Chief Executive Officer, Cytiva
Cytiva created its Biopharma Resilience Index about three years ago during the COVID-19 pandemic to better understand industry needs and trends. According to Ligner, the most recent survey asked about...
View ArticleBioProcess Insider Interview: Andrew Mears, Chief Executive Officer, Lead...
Despite the overall growth of the biopharmaceutical industry, talent shortages remain a problem across organizations from product manufacturing to research and development. According to Mears,...
View ArticleBioProcess Insider Interview: Min Park, Chief Business Officer, Aton Biotech
Moderator: Millie Nelson, Editor, BioProcess Insider. Featuring: Min Park, Chief Business Officer, Aton Biotech. In an industry with no shortage of contract development and manufacturing organizations...
View ArticleUnlocking the Power of Wizardry for Regulatory Compliance
Regulatory compliance is not just a legal requirement, but it is also a critical aspect of ensuring patient safety and trust. The consequences of noncompliance can be severe, incur costly fines, and...
View ArticleeBook: Outsourcing — Triumphs and Turmoil in Establishing Biologics CDMOs
Outsourced development and manufacturing once were all but out of the question in the biopharmaceutical industry. Regulatory changes, technical and scientific advances, and an increasingly global...
View ArticleProfessional Attire Guidelines for Bioprocessing
The global biotechnology industry has undergone a significant period of growth over the past three to four years. The COVID-19 pandemic accelerated the size and importance of an already growing sector,...
View ArticleAchieving Success with a Life-Sciences Start-Up Company
If you are an ambitious life-science professional seeking to create the next big innovation, starting your own company can enable you to share your ideas with the rest of the world. Opportunities...
View ArticleAccelerating Rare-Disease Drug Development: The Key Role of Patient Registries
In the United States, a rare disease is defined as a condition that affects fewer than 200,000 people nationwide. The World Health Organization defines a rare disease as a disorder that affects fewer...
View ArticleEnsuring Data Integrity in GxP
Our world provides us with abundant data at every moment of every day that we constantly analyze to make decisions. What is most important in a business/laboratory context is that the data we receive...
View ArticleReinventing How Drugs Are Invented: Making a Case for Simplicity in Drug...
The biopharmaceutical industry has entered into a creativity crisis. Despite billions in revenue, it has become a stagnant behemoth, struggling to deliver new therapies near the pace or price that the...
View Article